jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Culture & Sensitivity, Aerobic bacteria Throat Swab (Manual method)

Bacterial/ Viral
image

Report in 72Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

The throat swab culture test detects bacterial infections in the pharynx, tonsils, or throat.

2291,600

86% OFF

Culture & Sensitivity, Aerobic bacteria Throat Swab (Manual method)

  • Why is it done?
    • To identify and isolate aerobic bacteria causing throat infections or pharyngitis
    • To determine antibiotic susceptibility patterns of identified organisms to guide appropriate antimicrobial therapy
    • To differentiate between bacterial and viral causes of sore throat
    • Performed when patients present with symptoms of bacterial pharyngitis including sore throat, fever, difficulty swallowing, and inflamed throat
    • Typically ordered when clinical symptoms suggest streptococcal or other bacterial infection resistant to initial empiric therapy
    • Used to identify carriers of pathogenic organisms in immunocompromised patients or recurrent infection cases
  • Normal Range
    • Normal/Negative Result: No pathogenic aerobic bacteria isolated or only normal flora present (commensal organisms such as alpha-hemolytic streptococci, Neisseria species, or Corynebacterium species)
    • Positive Result: Growth of pathogenic bacteria (e.g., Group A Streptococcus, Staphylococcus aureus, Streptococcus pyogenes, Haemophilus influenzae) with identification and antibiotic susceptibility results
    • Units of Measurement: Qualitative (presence/absence); Susceptibility reported as: Susceptible (S), Intermediate (I), or Resistant (R) based on disk diffusion or MIC values (μg/mL)
    • Interpretation Guidelines: Normal indicates no bacterial infection requiring antimicrobial therapy; Abnormal indicates bacterial infection with specific organism identification and antibiotic guidance for treatment decisions
  • Interpretation
    • No Growth or Normal Flora Only: Suggests viral etiology or no significant bacterial infection; Indicates symptoms are likely non-bacterial in origin; Antimicrobial therapy may not be warranted
    • Group A Streptococcus (GAS/Streptococcus pyogenes): Most common bacterial cause of acute pharyngitis; Confirms strep throat diagnosis; Susceptibility typically shows sensitivity to penicillin, amoxicillin, and first-generation cephalosporins; Treatment guidance for acute infection and prevention of sequelae
    • Staphylococcus aureus: Less common throat pathogen; May indicate secondary infection; MRSA status critical for therapy selection; Requires targeted antibiotic based on susceptibility results
    • Haemophilus influenzae: Potential pathogen in pharyngitis; Assessment for beta-lactamase production important; Fluoroquinolones or third-generation cephalosporins often effective
    • Susceptible (S) Organisms: Organism likely to respond to standard antibiotic therapy at recommended doses; First-line agents typically appropriate
    • Intermediate (I) Organisms: May respond to therapy but with reduced efficacy; Consider higher doses, longer duration, or alternative agents; Clinical response monitoring essential
    • Resistant (R) Organisms: Organism unlikely to respond to standard therapy; Alternative antibiotics must be selected; Treatment failure risk if inappropriate agent used
    • Factors Affecting Results: Prior antibiotic use may suppress growth of susceptible organisms; Improper specimen collection or storage reduces culture yield; Timing of collection relative to symptom onset; Concurrent viral infections may mask bacterial growth; Immunocompromised status may alter normal flora patterns
  • Associated Organs
    • Primary Organ System: Upper respiratory tract, specifically the pharynx and oropharynx; Includes throat, tonsils, and surrounding lymphoid tissue
    • Associated Conditions - Acute Infections: Acute pharyngitis/sore throat; Bacterial tonsillitis; Streptococcal throat infection; Community-acquired upper respiratory infection
    • Associated Conditions - Chronic/Recurrent: Recurrent streptococcal pharyngitis; Chronic carrier state; Recurrent tonsillitis; Immunocompromised states with recurrent infections
    • Diseases Diagnosed/Monitored: Streptococcal pharyngitis (strep throat); Staphylococcal pharyngitis; Haemophilus pharyngitis; Mixed bacterial infections; Secondary bacterial superinfection of viral pharyngitis
    • Potential Complications of Untreated Infections: Acute rheumatic fever (especially untreated GAS); Post-streptococcal glomerulonephritis; Abscess formation (peritonsillar, retropharyngeal); Scarlet fever; Toxic shock syndrome; Sepsis; Spread to adjacent tissues and organs
    • Associated Systemic Manifestations: Fever and constitutional symptoms; Lymph node enlargement (cervical lymphadenopathy); Systemic inflammatory response; Potential for bacteremia and seeding to distant sites
  • Follow-up Tests
    • Tests for Treatment Confirmation: Post-treatment throat culture (if recurrent symptoms or treatment failure); Follow-up rapid strep test if initial culture negative but clinical suspicion remains high
    • Tests for Complication Screening: Anti-streptococcal antibodies (ASO titer) if acute rheumatic fever suspected; Urinalysis if post-streptococcal glomerulonephritis suspected; Blood culture if signs of sepsis or bacteremia
    • Diagnostic Tests for Differential Diagnosis: Rapid strep test or antigen detection if culture results delayed; Viral respiratory panel (RSV, influenza, coronavirus) if viral etiology suspected; Viral serology in select cases
    • Imaging Studies if Complications Suspected: CT neck or ultrasound if abscess formation suspected; Chest X-ray if signs of lower respiratory tract involvement
    • Monitoring in Carriers and Recurrent Cases: Repeat cultures if carrier status confirmed and treatment considered; Immunological assessment in immunocompromised patients with recurrent infection; Consider repeat culture 2-3 months after completion of antibiotics if recurrent infection
    • Related Complementary Tests: Complete blood count (CBC) to assess inflammatory response; Comprehensive metabolic panel if concerned about renal involvement; C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) for inflammatory markers
    • Testing Frequency and Monitoring: Single culture typically sufficient for diagnosis; No routine test-of-cure recommended unless specific complications present; For recurrent infections: cultures with each episode to confirm organism and resistance patterns; Long-term prophylaxis may be considered if multiple recurrences without need for repeat cultures
  • Fasting Required?
    • Fasting Required: No
    • Patient Preparation Instructions: No fasting required; Patients may eat and drink normally; No special dietary restrictions
    • Specimen Collection Timing: Collect throat swab when patient is in upright or semi-recumbent position; Perform collection ideally within first 3-5 days of symptom onset for optimal culture yield; Early morning collection preferred; Avoid collection immediately after eating, drinking, or oral hygiene to prevent contamination
    • Medications to Avoid Before Test: Recent oral antibiotics may suppress bacterial growth and reduce culture sensitivity; If patient has been on antibiotics, ideally wait at least 48 hours after completion before culture, or note antibiotic use on specimen requisition; Continue prescribed antibiotics as directed by physician even if test ordered
    • Specimen Collection Instructions: Use sterile cotton swabs or Dacron swabs (not calcium alginate) for collection; Obtain swab from posterior pharynx, tonsillar areas, and areas of inflammation or exudate; Avoid touching other oral structures (lips, tongue, teeth); Place swab in appropriate sterile collection tube with or without transport medium as per laboratory protocol; Ensure proper tube labeling with patient identifier, date, and time
    • Specimen Handling and Transport: Deliver specimen to laboratory within 2 hours of collection if transport medium used; Transport medium maintains viability of aerobic bacteria; Avoid exposure to extreme temperatures; Do not refrigerate specimens; Keep specimens at room temperature until processing
    • Additional Patient Instructions: Inform patients that collection may produce gagging or mild discomfort; Allow patient to relax and breathe through mouth during collection; Notify laboratory if patient has difficulty with specimen collection; Report any topical throat medications or lozenges used prior to collection

How our test process works!

customers
customers